down arrow

Shukra Pharma.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE551C01044
  • NSEID:
  • BSEID: 524632
INR
18.62
-0.38 (-2.0%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 7.11 k

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

18.6218.62

52 Week

5.7527.15
Valuation
Technical
Day's Volume

CASH

7.11 k (-19.38%) Volume

Shareholding (Dec 2024)

FII

0.00%

Held by 0 FIIs

DII

0.11%

Held by 0 DIIs

Promoter

50.96%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

Negative results in Dec 24

  • NET SALES(Latest six months) At Rs 16.14 cr has Grown at -62.92%
  • PAT(Q) At Rs 3.16 cr has Fallen at -12.5% (vs previous 4Q average)
2

With ROE of 15.1, it has a Very Expensive valuation with a 15.3 Price to Book Value

3

Despite the size of the company, domestic mutual funds hold only 0% of the company

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 815 Cr (Micro Cap)

stock-summary
P/E

102.00

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.53%

stock-summary
Debt Equity

-0.28

stock-summary
Return on Equity

15.07%

stock-summary
Price to Book

15.32

Revenue and Profits (1 Year):
Net Sales:
11 Cr
(Quarterly Results - Dec 2024)
Net Profit:
3 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0.53%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
169.27%
0%
169.27%
1 Year
133.0%
0%
133.0%
2 Years
1286.96%
0%
1286.96%
3 Years
5215.27%
16.25%
5231.52%
4 Years
7506.14%
11.53%
7517.67%
5 Years
7959.6%
31.15%
7990.75%

Latest dividend: 1 per share ex-dividend date: Sep-23-2024

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
23.74%
EBIT Growth (5y)
45.59%
EBIT to Interest (avg)
4.44
Debt to EBITDA (avg)
1.64
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.71
Tax Ratio
25.68%
Dividend Payout Ratio
5.91%
Pledged Shares
0
Institutional Holding
0.11%
ROCE (avg)
5.87%
ROE (avg)
11.29%
Valuation key factors
Factor
Value
P/E Ratio
102
Industry P/E
33
Price to Book Value
15.32
EV to EBIT
112.49
EV to EBITDA
82.91
EV to Capital Employed
20.95
EV to Sales
27.04
PEG Ratio
NA
Dividend Yield
0.53%
ROCE (Latest)
33.47%
ROE (Latest)
15.07%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

Anar Project Private Limited (18.78%)

Highest Public shareholder

Yogesh Biharilal Parikh (19.18%)

Individual Investors Holdings

9.41%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Dec'24 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is 90.29% vs 74.84% in Sep 2024",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is 485.19% vs 10.20% in Sep 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "10.58",
          "val2": "5.56",
          "chgp": "90.29%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "3.94",
          "val2": "0.67",
          "chgp": "488.06%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.15",
          "val2": "0.11",
          "chgp": "36.36%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "3.16",
          "val2": "0.54",
          "chgp": "485.19%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "37.24%",
          "val2": "12.05%",
          "chgp": "25.19%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is -80.51% vs 335.37% in Sep 2023",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is -80.12% vs 1,182.50% in Sep 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "8.73",
          "val2": "44.80",
          "chgp": "-80.51%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1.47",
          "val2": "5.43",
          "chgp": "-72.93%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.17",
          "val2": "0.15",
          "chgp": "13.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "1.02",
          "val2": "5.13",
          "chgp": "-80.12%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "16.84%",
          "val2": "12.12%",
          "chgp": "4.72%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is -69.68% vs 405.88% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is -71.27% vs 3,283.72% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "19.31",
          "val2": "63.69",
          "chgp": "-69.68%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "5.41",
          "val2": "14.97",
          "chgp": "-63.86%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.32",
          "val2": "0.22",
          "chgp": "45.45%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "4.18",
          "val2": "14.55",
          "chgp": "-71.27%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "28.02%",
          "val2": "23.50%",
          "chgp": "4.52%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is 26.76% vs 187.12% in Mar 2023",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is 320.41% vs 488.00% in Mar 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "74.57",
          "val2": "58.83",
          "chgp": "26.76%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "19.40",
          "val2": "5.36",
          "chgp": "261.94%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.29",
          "val2": "0.28",
          "chgp": "3.57%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "18.54",
          "val2": "4.41",
          "chgp": "320.41%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "26.02%",
          "val2": "9.11%",
          "chgp": "16.91%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Standalone) - Dec'24 - QoQstock-summary
Dec'24
Sep'24
Change(%)
Net Sales
10.58
5.56
90.29%
Operating Profit (PBDIT) excl Other Income
3.94
0.67
488.06%
Interest
0.15
0.11
36.36%
Exceptional Items
0.00
0.00
Standalone Net Profit
3.16
0.54
485.19%
Operating Profit Margin (Excl OI)
37.24%
12.05%
25.19%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2024 is 90.29% vs 74.84% in Sep 2024

Direction Arrows
Standalone Net Profit

QoQ Growth in quarter ended Dec 2024 is 485.19% vs 10.20% in Sep 2024

All Quarterly Resultsstock-summary
Half Yearly Results Snapshot (Standalone) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
8.73
44.80
-80.51%
Operating Profit (PBDIT) excl Other Income
1.47
5.43
-72.93%
Interest
0.17
0.15
13.33%
Exceptional Items
0.00
0.00
Standalone Net Profit
1.02
5.13
-80.12%
Operating Profit Margin (Excl OI)
16.84%
12.12%
4.72%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is -80.51% vs 335.37% in Sep 2023

Direction Arrows
Standalone Net Profit

Growth in half year ended Sep 2024 is -80.12% vs 1,182.50% in Sep 2023

All Half Yearly Resultsstock-summary
Nine Monthly Results Snapshot (Standalone) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
19.31
63.69
-69.68%
Operating Profit (PBDIT) excl Other Income
5.41
14.97
-63.86%
Interest
0.32
0.22
45.45%
Exceptional Items
0.00
0.00
Standalone Net Profit
4.18
14.55
-71.27%
Operating Profit Margin (Excl OI)
28.02%
23.50%
4.52%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is -69.68% vs 405.88% in Dec 2023

Direction Arrows
Standalone Net Profit

YoY Growth in nine months ended Dec 2024 is -71.27% vs 3,283.72% in Dec 2023

All Nine Monthly Resultsstock-summary
Annual Results Snapshot (Standalone) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
74.57
58.83
26.76%
Operating Profit (PBDIT) excl Other Income
19.40
5.36
261.94%
Interest
0.29
0.28
3.57%
Exceptional Items
0.00
0.00
Standalone Net Profit
18.54
4.41
320.41%
Operating Profit Margin (Excl OI)
26.02%
9.11%
16.91%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is 26.76% vs 187.12% in Mar 2023

Direction Arrows
Standalone Net Profit

YoY Growth in year ended Mar 2024 is 320.41% vs 488.00% in Mar 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Shukra Pharmaceuticals Ltd stock-summary
stock-summary
Shukra Pharmaceuticals Ltd
Micro Cap
Pharmaceuticals & Drugs
Shukra Pharmaceuticals Limited (Formerly known Relish Pharmaceuticals Limited) was established in March, 1993 and later on the Company name was changed from Relish Pharmaceuticals Limited to Shukra Pharmaceuticals Limited effective on September 22, 2016. The Company is presently engaged in the business of manufacturing and trading of pharmaceuticals formulations and laboratory testing. The company provides varieties of products to the clientele.
Company Coordinates stock-summary
Company Details
3 rd Floor Dev House, Opp WIAA Office Judges Bungalo Ahmedabad Gujarat : 380054
stock-summary
Tel: 91-079-66522247/27498515
stock-summary
http://www.shukrapharmeceuticals.com
stock-summary
info@relishpharma.com
Registrar Details
Purva Shareregistry (India) Pvt Ltd , Gala No 9, Shiv Shakti, Industrial Estate,Sitaram Mill Comp., J R Boricha Marg, Lower Parel [E], Mumbai
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."